Literature DB >> 24510524

Clonotype-specific avidity influences the dynamics and hierarchy of virus-specific regulatory and effector CD4(+) T-cell responses.

Jie Liu1, Shirley Cao, Gretchen Peppers, Sung-Han Kim, Barney S Graham.   

Abstract

A key component of immunity against viruses, CD4(+) T cells expand and differentiate into functional subsets upon primary infection, where effector (Teff) cells facilitate infection control and regulatory (Treg) cells mitigate immunopathology. After secondary infection, Teff cells mount a robust response from the memory pool. Here, we show that Treg-cell responses are diminished upon secondary infection, and Treg-cell response dynamics are associated more with T-cell receptors (TCRs) repertoire and avidity than with epitope specificity. In the murine model, the IA(b) M209 epitope of respiratory syncytial virus is recognized by both CD4(+) Treg and Teff cells, while the IA(b) M226 epitope is recognized almost exclusively by CD4(+) Teff cells expressing high avidity TCR Vβ8.1/8.2 and dominating the CD4(+) T-cell response during primary and secondary infections. IA(b) M209 -Teff cells express relatively low avidity TCRs during early primary infection, but high avidity TCR Vβ7-expressing IA(b) M209 -Teff cells emerge during the late phase, and become dominant after secondary infection. The emerging high avidity IA(b) M209 -Teff cells outcompete IA(b) M209 -Treg cells that share the same epitope, but have low avidity and are restricted to TCR Vβ2 and Vβ6 subpopulations. These data indicate that MHC-peptide-TCR interactions can produce different kinetic and functional profiles in CD4(+) T-cell populations even when responding to the same epitope. Published 2014. This article is a U.S. Government work and is in the public domain in the USA.

Entities:  

Keywords:  Precursor frequency; Respiratory syncytial virus; T-cell hierarchy; T-cell receptor (TCR) avidity; Treg cell

Mesh:

Substances:

Year:  2014        PMID: 24510524     DOI: 10.1002/eji.201343766

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  8 in total

1.  Identification of Novel Respiratory Syncytial Virus CD4+ and CD8+ T Cell Epitopes in C57BL/6 Mice.

Authors:  Megan E Schmidt; Steven M Varga
Journal:  Immunohorizons       Date:  2019-01-14

2.  T-Cell Receptor Diversity and the Control of T-Cell Homeostasis Mark Ebola Virus Disease Survival in Humans.

Authors:  Emily Speranza; Paula Ruibal; Julia R Port; Feng Feng; Lia Burkhardt; Adam Grundhoff; Stephan Günther; Lisa Oestereich; Julian A Hiscox; John H Connor; César Muñoz-Fontela
Journal:  J Infect Dis       Date:  2018-11-22       Impact factor: 5.226

Review 3.  Immunology studies in non-human primate models of tuberculosis.

Authors:  JoAnne L Flynn; Hannah P Gideon; Joshua T Mattila; Philana Ling Lin
Journal:  Immunol Rev       Date:  2015-03       Impact factor: 12.988

Review 4.  The role of Th17 and Treg responses in the pathogenesis of RSV infection.

Authors:  Thomas C Mangodt; Mikhaïl A Van Herck; Sara Nullens; José Ramet; Jozef J De Dooy; Philippe G Jorens; Benedicte Y De Winter
Journal:  Pediatr Res       Date:  2015-08-12       Impact factor: 3.756

5.  Memory of Inflammation in Regulatory T Cells.

Authors:  Joris van der Veeken; Alvaro J Gonzalez; Hyunwoo Cho; Aaron Arvey; Saskia Hemmers; Christina S Leslie; Alexander Y Rudensky
Journal:  Cell       Date:  2016-08-04       Impact factor: 41.582

6.  Characteristics of inflammatory reactions during development of liver abscess in hamsters inoculated with Entamoeba nuttalli.

Authors:  Yue Guan; Meng Feng; Xiangyang Min; Hang Zhou; Yongfeng Fu; Hiroshi Tachibana; Xunjia Cheng
Journal:  PLoS Negl Trop Dis       Date:  2018-02-08

Review 7.  Role of CD4+ T Cells in the Control of Viral Infections: Recent Advances and Open Questions.

Authors:  Jérôme Kervevan; Lisa A Chakrabarti
Journal:  Int J Mol Sci       Date:  2021-01-07       Impact factor: 5.923

Review 8.  Identifying Individual T Cell Receptors of Optimal Avidity for Tumor Antigens.

Authors:  Michael Hebeisen; Mathilde Allard; Philippe O Gannon; Julien Schmidt; Daniel E Speiser; Nathalie Rufer
Journal:  Front Immunol       Date:  2015-11-18       Impact factor: 7.561

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.